Phosphatonins: From Discovery to Therapeutics
Endocrine Practice（2023）
摘要
The treatment paradigm for XLH and TIO is changing based on data from recent clinical trials. Research suggest that burosumab is effective and safe for pediatric and adult patients with XLH or TIO.
更多查看译文
关键词
fibroblast growth factor 23,hypophosphatemia,osteomalacia,phosphatonin,rickets,vitamin D
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要